What is the market doing?
What the tape says about BCAX
Bicara Therapeutics Inc. is +107% over the past year while the S&P 500 is +20%: 87 points ahead of the market.
+107%
1-year return · S&P 500 +20%
- vs 200-day average
- +18%
vs 200-day average · a clear uptrend
- RSI (14)
- 42
RSI (14) · neutral
- Below its 52-week high
- 18%
Below its 52-week high
Details›
- Last close2026-09-08
- $23.73
- 1 monthS&P 500 −0.30%
- −14%
- 1 yearS&P 500 +20%
- +107%
- vs 50-day average$25.08
- −5.4%
- 52-week high
- $28.86
- 52-week low
- $10.44
- Annualised volatility
- 75%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- $4.8M
| Year | Return |
|---|---|
| 2026 (year to date) | +41% |
| 2025 | −3.4% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 2 | 0 of 2 | −14% |
| Feb | 2 | 1 of 2 | +2.6% |
| Mar | 2 | 1 of 2 | +8.3% |
| Apr | 2 | 2 of 2 | +9.4% |
| May | 2 | 1 of 2 | −17% |
| Jun | 2 | 2 of 2 | +11% |
| Jul | 2 | 2 of 2 | +11% |
| Aug | 2 | 1 of 2 | −3.2% |
| Sep | 2 | 2 of 2 | +17% |
| Oct | 2 | 1 of 2 | −2.1% |
| Nov | 2 | 1 of 2 | +1.0% |
| Dec | 2 | 0 of 2 | −13% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Biotechnology
Ranks #53 of 143 by Smart Score